» Articles » PMID: 31001286

Epstein-Barr Virus and MiRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis?

Overview
Journal Front Immunol
Date 2019 Apr 20
PMID 31001286
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that modulate gene expression post transcriptionally. In healthy individuals, miRNAs contribute to maintaining gene expression homeostasis. However, the level of miRNAs expressed is markedly altered in different diseases, including multiple sclerosis (MS). The impact of such changes is being investigated, and thought to shape the immune system into the inflammatory autoimmune phenotype. Much is yet to be learned about the contribution of miRNAs in the molecular pathology of MS. Epstein-Barr virus (EBV) infection is a major risk factor for the development of MS. EBV encodes more than 40 miRNAs, most of which have been studied in the context of EBV associated cancers. These viral miRNAs regulate genes involved in cell apoptosis, antigen presentation and recognition, as well as B cell transformation. If EBV infection contributes to the pathology of MS, it is plausible that EBV miRNAs may be involved. Unfortunately, there are limited studies addressing how EBV miRNAs are involved in the pathogenesis of MS. This review summarizes what has been reported regarding cellular and viral miRNA profiles in MS and proposes possible interactions between the two in the development of MS.

Citing Articles

The 'Oma's of the Gammas-Cancerogenesis by γ-Herpesviruses.

Banerjee A, Dass D, Mukherjee S, Kaul M, Harshithkumar R, Bagchi P Viruses. 2025; 16(12.

PMID: 39772235 PMC: 11680331. DOI: 10.3390/v16121928.


Research progress on the mechanism of exosome-mediated virus infection.

Zhang H, Liu X, Shi J, Su X, Xie J, Meng Q Front Cell Infect Microbiol. 2024; 14:1418168.

PMID: 38988816 PMC: 11233549. DOI: 10.3389/fcimb.2024.1418168.


Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseases.

Xu Y, Chen Y, Yang Q, Lu Y, Zhou R, Liu H Heliyon. 2024; 10(5):e26810.

PMID: 38444478 PMC: 10912469. DOI: 10.1016/j.heliyon.2024.e26810.


Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis.

Debuysschere C, Nekoua M, Hober D Microorganisms. 2023; 11(5).

PMID: 37317236 PMC: 10220565. DOI: 10.3390/microorganisms11051262.


Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers.

Ortega-Hernandez O, Martinez-Caceres E, Presas-Rodriguez S, Ramo-Tello C Int J Mol Sci. 2023; 24(8).

PMID: 37108566 PMC: 10138841. DOI: 10.3390/ijms24087407.


References
1.
Schwarz D, Hutvagner G, Du T, Xu Z, Aronin N, Zamore P . Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003; 115(2):199-208. DOI: 10.1016/s0092-8674(03)00759-1. View

2.
Yi R, Qin Y, Macara I, Cullen B . Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003; 17(24):3011-6. PMC: 305252. DOI: 10.1101/gad.1158803. View

3.
. Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. French Research Group on Multiple Sclerosis. Ann Neurol. 1992; 32(6):724-7. DOI: 10.1002/ana.410320604. View

4.
Masucci M . Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system. Oncogene. 2004; 23(11):2107-15. DOI: 10.1038/sj.onc.1207372. View

5.
Lee Y, Kim M, Han J, Yeom K, Lee S, Baek S . MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23(20):4051-60. PMC: 524334. DOI: 10.1038/sj.emboj.7600385. View